nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Anxiety/Stress-Related Disorders"

 

FDA Approves PTSD Sleep Device for Nightmares
November 11, 2020   

The U.S. Food and Drug Administration granted marketing authorization of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder...
 Continue reading (Members only)
FDA Requiring Stronger Warning Label For Benzodiazepines
September 25, 2020   

The US Food and Drug Administration has ordered changes to the labeling for benzodiazepines, requiring them to include information on the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions. Benzodiazepines are...
 Continue reading
NEI Virtual Poster Library is Live!
July 13, 2020   

NEI has launched a Virtual Poster Library to fulfill the needs of poster presenters who had hoped to share their research and findings at medical conferences that have been cancelled due to the COVID-19 pandemic....
 Continue reading
Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020   

With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions...
 Continue reading
FDA Bans Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior
March 23, 2020   

The U.S. Food and Drug Administration (FDA) bans electrical stimulation devices used for self-injurious or aggressive behavior because they present...
 Continue reading (Members only)
Severe Clinical Consequences of Childhood Abuse and Neglect
February 10, 2020   

l infarction, cerebrovascular disease, type 2 diabetes, asthma, cancer, and overall lowered life expectancy. In this article, the authors review the current state of research regarding the association of early childhood abuse/neglect with development of psychiatric illness, particularly mood disorders such as...
 Continue reading (Members only)
Meta-analysis Shows No Effect of Omega-3 for Prevention or Treatment of Depression and Anxiety
November 25, 2019   

Many individuals suffering from mental health disorders, such as depression and anxiety, turn to the use of complementary and alternative medications (CAMs). One such CAM is polyunsaturated fatty acids...
 Continue reading (Members only)
FDA Approves New Cranial Electrotherapy Stimulator—Integrated Into a Stereo Headset
April 11, 2019   

The Food and Drug Administration (FDA) has approved a new cranial electrotherapy stimulator for treatment of anxiety, depression, and insomnia. The device, Cervella, is operated using...
 Continue reading (Members only)
Risk of PTSD and Major Depression After Mild Traumatic Brain Injury
March 25, 2019   

A prospective cohort study was recently conducted to examine the relationship between mild traumatic brain injury (mTBI) and comorbid mental health conditions. The study included 1155 patients with mTBI and 230 patients with orthopedic injuries not involving the head. Patients with mTBI were more likely to...
 Continue reading (Members only)
MDMA for the Treatment of PTSD
August 27, 2018   

Although still investigational, the psychogenic compound 3,4-methylenedioxymethamphetamine (MDMA) -administered in conjunction with psychotherapy- has shown long-lasting benefit to patients suffering with PTSD....
 Continue reading (Members only)
1234
Top of Page